Cash Flow Statement

Cash from Financing Activities Cash from Operations Change in Account Payables Change in Accured Expenses Change in Cash Change in Receivables Depreciation & Amortization (CF)Exchange Rate Effect Free Cash Flow Gains from Investment Securities Gains from Sales and Divestitures Net Cash Flow Net Income Non-cash Items Other Working Capital Changes Other financing activities Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Ratios

Neuphoria Therapeutics (NEUP) Other financing activities (2024 - 2025)

Neuphoria Therapeutics (NEUP) has disclosed Other financing activities for 2 consecutive years, with $100000.0 as the latest value for Q3 2025.